Trial Profile
Phase II trial of ordopidine
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2010
Price :
$35
*
At a glance
- Drugs Ordopidine (Primary)
- Indications Drug-induced dyskinesia; Parkinson's disease
- Focus Therapeutic Use
- Sponsors NeuroSearch
- 26 Aug 2010 The trial is expected to start in the first half of 2011.
- 30 Nov 2007 New trial record.